EWA
IDYA icon

EverSource Wealth Advisors’s IDEAYA Biosciences IDYA Stock Holding History

EverSource Wealth Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.78K Buy
155
+19
+14% +$582 ﹤0.01% 3217
2026
Q1 		$4.53K Sell
136
-140
-51% -$4.7K ﹤0.01% 3313
2025
Q4 		$9.54K Buy
276
+4
+1% +$128 ﹤0.01% 2823
2025
Q3 		$7.4K Sell
272
-14
-5% -$339 ﹤0.01% 2974
2025
Q2 		$6.01K Buy
286
+264
+1,200% +$5.07K ﹤0.01% 3074
2025
Q1 		$360 Buy
22
+19
+633% +$405 ﹤0.01% 3564
2024
Q4 		$77 Sell
3
-11
-79% -$311 ﹤0.01% 3588
2024
Q3 		$444 Hold
14
– – ﹤0.01% 2897
2024
Q2 		$603 Buy
+14
New +$554 ﹤0.01% 2848

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

EverSource Wealth Advisors's IDYA Position: Q2 2026 in Review

EverSource Wealth Advisors increased its IDEAYA Biosciences (IDYA) stake by 14% in Q2 2026, buying an estimated $582 and bringing the position to 155 shares worth $5.78K. The position accounts for ﹤0.01% of the portfolio, ranked #3217.

EverSource Wealth Advisors first reported a position in IDYA in Q2 2024 and has held it in 9 quarters since. The position peaked at $9.54K in Q4 2025. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • EverSource Wealth Advisors held 155 shares of IDEAYA Biosciences worth $5.78K as of Q2 2026.
  • EverSource Wealth Advisors bought 19 IDEAYA Biosciences shares in Q2 2026, an estimated $582.
  • IDEAYA Biosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3217 holding.
  • EverSource Wealth Advisors first reported a position in IDEAYA Biosciences in Q2 2024 and has held it in 9 quarters since.
  • EverSource Wealth Advisors's IDEAYA Biosciences position peaked at $9.54K in Q4 2025.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.